BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (pSer33) Peptid
BIK
Reaktivität: Human
Wirt: Synthetic
BP
Kurzübersicht für BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (pSer33) Peptid (ABIN2710832)
Target
BIK
(BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP)
-
-
Protein Region
- pSer33
-
Produktmerkmale
- The peptide is used to block Anti-BIK (pT33) Antibody reactivity.
-
-
-
-
Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
-
Haltbarkeit
- 12 months
-
-
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
-
Hintergrund
- NBK, Bcl-2-interacting killer, Apoptosis inducer NBK, BIP1, BP4
-
Gen-ID
- 638
-
UniProt
- Q13323
Target
-
Sie sind hier:
